Empower India Reports Profit Amid Auditor Delay

Empower India Ltd has released its unaudited financial results for the nine months and quarter ending December 31, 2025. The company posted consolidated profit before tax of ₹406.82 lakh (₹4.07 crore) on consolidated revenue from operations of ₹10906.39 lakh (₹109.06 crore) for the nine-month period. The Board of Directors approved these unaudited results on February 13, 2026, with the submission date noted as May 15, 2026.

Auditor's Health Delays Mandatory Review

A significant development accompanying the results is the critical illness of the company's statutory auditor, who is currently hospitalized. This unforeseen health issue has led to a delay in the submission of the mandatory Limited Review Report.

Impact on Investor Confidence and Compliance

The timely submission of reviewed financial statements is crucial for investor confidence and regulatory adherence. The delay in the Limited Review Report, particularly due to the auditor's health, introduces a period of uncertainty. Investors may find it more challenging to fully assess Empower India's financial health and performance trends without the auditor's independent verification. This situation also raises questions about the continuity of the audit process.

Standalone Financial Performance

In addition to consolidated results, Empower India also reported standalone figures. For the nine months ended December 31, 2025, standalone revenue from operations stood at ₹75.67 crore (₹7567.32 lakh), with a standalone profit before tax of ₹1.83 crore (₹183.17 lakh).

Next Steps and Risks

Empower India's immediate focus will be on securing the Limited Review Report once the auditor's condition permits. The company faces the task of managing regulatory filings proactively. Investors will be closely watching for updates regarding the auditor's health, the timeline for completing the review, and any communications from the stock exchange concerning the delay. Additionally, the financial performance for the upcoming fourth quarter of fiscal year 2026 will be a key area of interest.

Risks associated with this situation include potential prolonged delays leading to non-compliance or exchange scrutiny. The prevailing uncertainty could also negatively impact investor sentiment and the company's stock performance.